Dive deeper

Open any topic for the full explanation, tables, clinical checkpoints, and references.

Full-length video Where can I learn more about what happens on Mohs surgery day?

A complete visual guide

Watch the full explanation on YouTube A complete visual review with the supporting clinical context.
What job is Mohs surgery doing before repair?

First, Understand the Job Mohs Is Doing

A skin cancer has a visible part and a microscopic border. Those borders are not always the same. Tumor cells can extend beyond what the eye sees, grow along a scar, follow a nerve, or send an irregular projection beneath normal-looking skin.

Every skin-cancer operation has to answer two questions:

  1. Was enough cancer removed?
  2. How should the resulting wound be repaired?

Mohs deliberately answers them in that order. The cancer is removed in mapped stages. The tissue is processed so the surgeon can examine the peripheral margin around the sides and the deep margin underneath. If a mapped area is positive, more tissue is removed from that location—not automatically from the entire wound. When the examined margin is clear, the true wound is known and the repair decision can be made.1–3

That sequence is especially valuable when a tumor is high risk, recurrent, aggressive, poorly defined, or located where preserving healthy tissue matters.

What Mohs surgery terms should I understand?

The Minimum Vocabulary

Margin

A margin is the surgical border around and beneath the removed cancer. The peripheral margin surrounds the sides. The deep margin lies underneath.

Stage

A Mohs stage is one mapped layer removed and examined. A stage is not a cancer stage such as stage I or stage II. It is one cycle of removal, processing, and microscopic review.

Map

The map links each part of the removed tissue to a precise location on the patient. A positive area on the slide can therefore direct the next surgical layer.

Clear margin

A clear margin means no tumor is seen at the properly processed peripheral and deep border examined during that stage. It does not mean a lifetime guarantee. No skin-cancer treatment prevents every recurrence or every new cancer.

Repair or reconstruction

The repair is what happens to the cancer-free wound: stitches in a line, a local flap, a skin graft, natural healing without stitches, a staged operation, or reconstruction by another surgeon.

How should I prepare before leaving home?

Before You Leave Home

The written instructions from the team performing your surgery control. A general article cannot know whether sedation, a medical condition, an eye-area operation, or a planned reconstruction changes the routine.

For a typical Mohs procedure under local anesthesia, preparation often includes:

  • eating normally unless the team says otherwise;
  • taking usual prescription medicines unless a coordinated plan changes them;
  • bringing a current medicine and allergy list;
  • confirming the exact biopsy site, especially when the spot has healed or several sites were biopsied;
  • arranging a driver if sedation, an eye-area dressing, or another safety issue makes driving unwise; and
  • planning for an unpredictable finish time.

Do not independently stop aspirin, warfarin, clopidogrel, apixaban, rivaroxaban, dabigatran, or another prescribed antithrombotic. A medicine change should balance bleeding and clotting risk with the clinicians who know why the medicine was prescribed.4–7

Bring what the office permits for a waiting day: water, food if allowed, a charger, reading material, and comfortable layers. Preparation cannot predict the number of stages, but it can remove avoidable stress.

What happens at arrival and during local anesthesia?

Arrival, Site Confirmation, and Local Anesthesia

The team confirms the patient, diagnosis, operation, site, allergies, medicines, and relevant health history. The surgeon may compare the skin with a biopsy photograph, pathology information, or the referring clinician's mark. This pause matters. The best margin technique cannot correct an operation performed at the wrong site.

Local anesthetic is injected around the tumor. The first injection can sting or burn for several seconds. After the area is numb, pressure, pulling, movement, vibration, or touch may still be felt; sharp pain should not be expected. Tell the team if the area is not adequately numb.

Buffering an anesthetic, warming it, injecting slowly, cooling the skin, or using vibration can reduce injection discomfort in some settings. A systematic review of 23 periocular-surgery studies involving 1,135 patients found benefit from several of these strategies.8 That evidence is useful but indirect: periocular procedures are not identical to every Mohs case, and not every office uses every technique. The honest promise is comfort measures may reduce the sting, not “the injection will be painless.”

What happens during the Mohs cycle?

The Mohs Cycle, Step by Step

  1. The visible tumor and a thin surgical layer are removed. The exact approach varies with the tumor and site.
  2. The specimen is oriented and mapped. Marks, colors, divisions, and a drawing preserve location.
  3. Bleeding is controlled and the wound is covered. The patient usually leaves the procedure room to wait.
  4. The tissue is processed. It is flattened or otherwise prepared, frozen, cut into thin sections, stained, and mounted on microscope slides.
  5. The Mohs surgeon examines the slides. The properly processed peripheral and deep margin is reviewed for residual tumor.
  6. A positive area directs the next stage. More tissue is removed only from the mapped location where cancer remains.
  7. The cycle ends when the examined margin is clear. The surgeon can then evaluate the true wound and choose the repair.1–3

What “100% border protection in one visit” means

You may hear Mohs described as “100% border protection in one visit.” Treat that as an analogy for the margin method, not a cure-rate promise.

  • “Border” means the properly processed peripheral and deep surgical margin.
  • “100%” refers to examination of the properly processed peripheral and deep margin rather than a set of representative cross-sections.
  • “One visit” means the mapping, slide review, and directed additional stages usually occur during the same episode of care.

It does not mean every cell in the removed tumor is placed on a slide. It does not mean tissue processing can never be imperfect. It does not mean recurrence is impossible. The strength of Mohs is complete mapped margin assessment with tissue conservation—not magical certainty.

Why does Mohs surgery require waiting?

Why the Waiting Is Necessary

Mohs is not one uninterrupted operation. Much of the day may be laboratory time.

Why the Waiting Is Necessary
Part of the visitWhat is happeningWhat the step adds
Surgical stageA mapped layer is removed under local anesthesiaRemoves the visible tumor and creates a precise tissue map
Tissue processingThe specimen is oriented, frozen, cut, stained, and mountedMakes the peripheral and deep border readable
Microscopic reviewThe Mohs surgeon examines the slidesShows whether tumor remains and where it is located
Directed next stageAdditional tissue is taken only from a positive mapped areaPreserves uninvolved tissue instead of widening the whole wound
Repair planningThe clear wound is assessed for function, anatomy, and closure optionsMatches reconstruction to the wound that actually exists

The visible spot cannot reliably predict microscopic extension. A small biopsy scar can hide a broad tumor. A larger visible lesion can sometimes clear in one stage. That is why a responsible team cannot promise the number of stages or the departure time before the slides are read.

How does complete margin examination change the plan?

What Complete Margin Examination Changes

Standard excision and Mohs are both legitimate operations, but they organize pathology differently. Standard excision usually removes a planned margin and sends the specimen for later permanent-section pathology using representative vertical sections. Mohs maps the tissue and examines the properly processed peripheral and deep margin during the operation.1–3,9

What Complete Margin Examination Changes
QuestionMohs surgeryStandard excision
When is the margin read?During the staged visitUsually after the operation
How is location preserved?The specimen is mapped so a positive area directs the next layerOrientation may identify margins, but representative sections leave intervals between examined slices
What happens if a margin is positive?Another layer is usually taken from the mapped positive area during the same visitA later re-excision or another treatment plan may be needed
When is the final wound known?After mapped clearance during the visitThe wound is known immediately, but final pathology may arrive later
Can repair be immediate?Often, after clear Mohs marginsYes in many selected cases; delayed or staged repair may be chosen when clearance risk or the reconstruction plan warrants it

This table does not make standard excision an inferior operation for every tumor. Wide local or standard excision remains appropriate for many well-defined cancers and is the usual foundation for most invasive melanoma. The difference is the margin workflow, and that difference matters most when hidden extension, recurrence, tissue preservation, or a major repair raises the cost of an uncertain border.9–11

What happens after the margin is clear?

After the Margin Is Clear: Repair Is a New Decision

Only now does the surgeon know the true size, depth, shape, and location of the cancer-free wound. Options can include:

  • a linear closure;
  • a local flap;
  • a skin graft;
  • natural healing without stitches;
  • a staged repair;
  • a delayed repair; or
  • coordinated reconstruction by another specialist.

Same-day repair is common because Mohs provides margin information during the visit. A Medicare analysis estimated 558,447 Mohs cases in 2009; in its 5% claims sample, 65.8% had a same-day repair code.12 A later network study found a higher proportion, illustrating how year, database, and coding affect the estimate.13 Neither result means every remaining wound had an unexpected delay. Claims data can mix natural healing, planned staging, outside referral, and incomplete coding.

Some wounds should heal naturally. Some repairs are safer after swelling settles or after additional planning. Some larger or specialized reconstructions are coordinated with another surgeon. Some staged flaps require more than one operation by design. The principle is not “same day at all costs.” It is clear the cancer, understand the wound, then choose the repair that best protects function and appearance.14

What evidence puts Mohs surgery in context?

Evidence by the Numbers

Evidence by the NumbersSeveral simple techniques can reduce the sting of local anesthetic

Several simple techniques can reduce the sting of local anesthetic

23 studies; 1,135 patients

Population
Patients in a systematic review of local-anesthetic injection techniques used in periocular surgery
Outcome
Injection pain with buffering, warming, dilution, slower injection, cooling, vibration, and other techniques
Time horizon
During injection

What it means: Buffering, warming, slow injection, and other comfort measures may make numbing more tolerable; patients should still expect a brief sting rather than a painless guarantee.

Limitations: The review was periocular-surgery evidence, not a Mohs-only trial, and the included studies and techniques varied.

References: 8

Evidence by the NumbersSame-day repair is common, but it is not a rule

Same-day repair is common, but it is not a rule

19% had no same-day repair code

Population
607,214 Mohs cases recorded in the TriNetX research network from 2006 through 2024
Outcome
Proportion without a same-day repair code; the remaining cases were categorized among same-day repair types
Time horizon
The Mohs episode from 2006 through 2024

What it means: Many patients have reconstruction during the same visit after margin clearance, while natural healing, planned staging, delayed repair, and referral remain valid pathways.

Limitations: Claims coding cannot reliably distinguish every deliberate no-repair, delayed-repair, outside-referral, or missing-code scenario; later datasets report different proportions.

References: 13

Evidence by the NumbersMohs has a strong outpatient safety record

Mohs has a strong outpatient safety record

0.72% total; 0.02% serious

Population
20,821 Mohs procedures in a prospective cohort at 23 US centers
Outcome
Thirty-day adverse events; 149 total events, 4 serious events, and no deaths
Time horizon
Thirty days

What it means: Large prospective data support the overall safety of outpatient Mohs, while one patient's risk still depends on health, site, and repair complexity.

Limitations: The cohort came from 21 private and 2 institutional ambulatory referral centers and pooled many tumor, patient, and repair types; an overall rate does not predict one complex reconstruction.

References: 15

What should I know before going home?

Before You Go Home

Leave with repair-specific instructions that answer:

  • What exactly was done?
  • How should this bandage and wound be managed?
  • Which pain medicines are appropriate for me?
  • What bathing and activity restrictions apply?
  • Which bleeding, swelling, drainage, fever, or pain should trigger a call?
  • When are sutures, dressing checks, or a second stage planned?
  • When will skin-cancer surveillance resume?

A graft, eyelid flap, lower-leg wound, natural-healing site, and simple linear closure do not share one universal schedule. The treating team's written instructions control.

What do realistic Mohs surgery examples show?

Realistic Examples

A recurrent BCC beside the nose

The biopsy scar looks small, but the first Mohs stage shows tumor extending toward the nostril. The next layer is taken only from that mapped area. After clearance, the wound is larger on one side than the original spot suggested, and the repair changes accordingly. This is the problem Mohs is built to solve.

A well-defined tumor that clears in one stage

The first layer is clear. The visit still included mapping, tissue processing, and microscopic examination. “One stage” does not mean the laboratory work was unnecessary; it means no additional mapped tumor was found.

A wound not repaired immediately

The cancer is clear, but the wound is allowed to heal naturally or is repaired later because that plan best fits its contour, health, or reconstructive needs. A delay after clear Mohs margins is not automatically a complication.

Frequently asked questions about Mohs surgery day

Frequently Asked Questions

How long will Mohs surgery take?

Plan for a substantial portion of the day. Each stage adds processing and slide-review time, and the repair can be brief or complex. An exact finish time cannot be promised in advance.

How many stages will I need?

Many tumors clear in one or a few stages, but the number depends on microscopic extension, not just visible size. A population average cannot predict one patient's tumor.

Does the Mohs surgeon also read the slides?

Yes. A defining feature of Mohs surgery is that the surgeon removes the tissue, maps it, and interprets the microscopic margins, connecting the slide directly to the surgical site.

Will I need general anesthesia?

Usually not for the Mohs stages. Most are performed with local anesthesia. Selected reconstructions may involve sedation, monitored anesthesia, or general anesthesia depending on the wound, patient, setting, and plan.

Will I know the cancer is gone that day?

You will know whether the properly processed peripheral and deep margins examined during Mohs are clear. That is strong same-day margin information, not a guarantee against every recurrence or new future skin cancer.

Why not design the flap before the cancer is removed?

Possible repairs can be discussed in advance, but the final design should fit the clear wound. Hidden tumor can change the wound's size, depth, and direction.

Can another surgeon perform the repair?

Yes. Many Mohs surgeons perform reconstruction themselves; other wounds are coordinated with plastic surgery, oculoplastic surgery, head-and-neck surgery, or another appropriate specialist. The important sequence is adequate cancer clearance before a major rearrangement obscures the original margin.

Should I stop my blood thinner?

Not on your own. Ask the Mohs team and prescribing clinician for an individualized plan.

What is the most useful question to ask before the day of surgery?

Ask: “How will I receive the site, medicine, transportation, margin, and repair instructions that apply to my case?”

Where should I go next in the Patient Journey?

Next Steps in the Patient Journey

After Mohs, move to the reconstruction pathway that matches the actual wound and repair plan. If the repair is not yet known, start with How Will My Skin Cancer Wound Be Repaired? If the wound will heal without stitches or involves the nose, eyelid, forehead flap, or another complex repair, use the matching branch-specific guide.

Continue with the question that fits you now

Who reviewed and authored this Mohs surgery guide?
Portrait of Dr. Thomas L.H. Hocker

About the Author

Dr. Thomas L.H. Hocker is a Harvard- and Mayo Clinic-trained, triple board-certified dermatologist, Mohs surgeon, and dermatopathologist. He is the Founding Director of Dermatologic Surgery at the UMKC School of Medicine and University Health and an Iron Surgeon lecturer at the American Society for Dermatologic Surgery. His work focuses on Mohs surgery for melanoma, complex and rare skin tumors, and aesthetic reconstruction after skin-cancer treatment. He co-authored the best-selling textbook Review of Dermatology and created Skin Trust to give patients and clinicians free access to clear, current, evidence-based education.

Read Dr. Hocker's background and mission

Dr. Hocker earned his bachelor's degree with honors from Yale University, where he was inducted into Phi Beta Kappa. As a Winston Churchill Scholar, he then studied at the University of Cambridge and earned an M.Phil. in Organic Chemistry. He received his M.D. with honors from Harvard Medical School, where his research focused on melanoma genetics. He completed dermatology residency at Mayo Clinic, a dermatopathology fellowship at the University of Michigan, and a Mohs micrographic and reconstructive surgery fellowship at Mayo Clinic. He is board-certified in Dermatology, Dermatopathology, and Mohs Micrographic Surgery.

Dr. Hocker serves as the Founding Director of Dermatologic Surgery at the UMKC School of Medicine and University Health. He is an internationally invited lecturer and speaker who teaches about Mohs surgery for melanoma, complex and rare tumors, dermatopathology, and aesthetic reconstruction after skin-cancer treatment. He has also been selected as an Iron Surgeon lecturer by the American Society for Dermatologic Surgery. He is the co-author of Review of Dermatology, a best-selling dermatology review textbook, and he continues to teach and mentor medical students, residents, and physicians.

Skin Trust exists because Dr. Hocker believes access to excellent medical knowledge should not depend on geography, wealth, or proximity to a major academic center. After training at several of the world's leading institutions, he sees that education as both a gift and a responsibility: to translate current evidence, expert judgment, and hard-won clinical experience into guidance that patients, families, and clinicians can actually use.

The mission is to increase awareness, reduce avoidable suffering, and give every person equal access to trustworthy, up-to-date information that can help them make the best decisions for their life. Skin Trust also extends Dr. Hocker's lifelong commitment to teaching, writing, and mentoring medical students and residents as they build lives and careers of purpose and service.

For Dr. Hocker, this work is also an expression of faith. He regards the opportunities to learn at Yale, Cambridge, Harvard, Mayo Clinic, and the University of Michigan as blessings from God. Teaching, writing, mentoring, and building Skin Trust are ways to pay those blessings forward in service to patients, learners, and the broader community. His faith is the personal motivation to do this work carefully, generously, and with integrity; it is not a condition of using or benefiting from this free resource.

View Review of Dermatology Read Dr. Hocker's full biography
References for this Mohs surgery day guide

References

  1. Tolkachjov SN, Brodland DG, Coldiron BM, et al. Understanding Mohs micrographic surgery: a review and practical guide for the nondermatologist. Mayo Clin Proc. 2017;92(8):1261-1271. PMID: 28778259. DOI: 10.1016/j.mayocp.2017.04.009.
  2. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Basal Cell Skin Cancer. Version 2.2026.
  3. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Squamous Cell Skin Cancer. Version 2.2026.
  4. Isted A, Cooper L, Colville RJ. Bleeding on the cutting edge: a systematic review of anticoagulant and antiplatelet continuation in minor cutaneous surgery. J Plast Reconstr Aesthet Surg. 2018;71(4):455-467. PMID: 29233507. DOI: 10.1016/j.bjps.2017.11.024.
  5. Iyengar S, Yeager DG, Cohen JL, Ozog DM. Update and review of bleeding considerations in dermatologic surgery: anticoagulants and antiplatelets. Dermatol Surg. 2020;46(2):192-201. PMID: 31743247. DOI: 10.1097/DSS.0000000000002266.
  6. Siscos SM, Neill BC, Hocker Singh A, Hocker TLH. Thrombotic complications with interruption of direct oral anticoagulants in dermatologic surgery. J Am Acad Dermatol. 2021;84(2):425-431. PMID: 33045293. DOI: 10.1016/j.jaad.2020.10.008.
  7. Ireland PA, Borruso L, Spencer SKR, et al. Direct oral anticoagulants in skin surgery: a systematic review of their complications and recommendations for perioperative management. Int J Dermatol. 2024;63(4):413-421. PMID: 38009338. DOI: 10.1111/ijd.16916.
  8. Gostimir M, Hussain A. A systematic review and meta-analysis of methods for reducing local anesthetic injection pain among patients undergoing periocular surgery. Ophthalmic Plast Reconstr Surg. 2019;35(2):113-125. PMID: 30664129. DOI: 10.1097/IOP.0000000000001209.
  9. Warne MM, Klawonn MM, Brodell RT. Bread loaf sections provide useful information on more than 0.5% of surgical margins. Br J Dermatol. 2022;187(5):812-813. PMID: 35788919. DOI: 10.1111/bjd.21740.
  10. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Melanoma: Cutaneous. 2026.
  11. van Loo E, Mosterd K, Krekels GA, et al. Surgical excision versus Mohs micrographic surgery for basal cell carcinoma of the face: a randomized clinical trial with 10-year follow-up. Eur J Cancer. 2014;50(17):3011-3020. PMID: 25262378. DOI: 10.1016/j.ejca.2014.08.018.
  12. Donaldson MR, Coldiron BM. Mohs micrographic surgery utilization in the Medicare population, 2009. Dermatol Surg. 2012;38(9):1427-1434. PMID: 22681892. DOI: 10.1111/j.1524-4725.2012.02464.x.
  13. Dowdle TS, Schmidt M, Winsett FT, Wagner RF. National trends in repair type selection after Mohs micrographic surgery: a benchmark analysis using TriNetX. Dermatol Surg. 2026;52(4):307-309. PMID: 40899759. DOI: 10.1097/DSS.0000000000004851.
  14. Chen A, Albertini JG, Bordeaux JS, et al. Evidence-based clinical practice guideline: reconstruction after skin cancer resection. J Am Acad Dermatol. 2021;85(2):423-441. PMID: 33931288. DOI: 10.1016/j.jaad.2021.03.015.
  15. Alam M, Ibrahim O, Nodzenski M, et al. Adverse events associated with Mohs micrographic surgery: multicenter prospective cohort study of 20,821 cases at 23 centers. JAMA Dermatol. 2013;149(12):1378-1385. PMID: 24080866. DOI: 10.1001/jamadermatol.2013.6255.